Page 40
Notes:
allied
academies
Nov 22-23, 2018 | Paris, France
Joint Event
Nutrition and Health
16
th
International Conference on
26
th
International Conference on
Diabetes and Endocrinology
&
Journal of Insights in Nutrition and Metabolism | Volume 2
Optimizing treatment for diabetic patients with integrated approach of behavioral management, food
science, artificial intelligence and pharmaceutical care
Ahmad Hussen Tareq
Nanyang Technological University, Singapore
D
iabetes is a major, non-communicable disease with
increasing prevalence at a global level. Optimized
diabetic care comprises of various factors. It starts from right
medications, frequent blood glucose monitoring, modification
in diet, increasing physical exertion and behavioral intervention
for patient compliance. Pharmaceutical care addresses the drug
related issues and assist in sustaining desired blood glucose
levels. However, lifestyle changes are the significant component
of diabetes management. To adjust with these changes’ patient
needs continuous education, motivation and monitoring. To
track patient progress, pharmaceutical care and behavioral
challenges, we are developing tool to manage clinical data,
applying artificial intelligence and data analytics to acquire
expedient actionable insights for the clinicians. Our focus is
to resolve behavioral challenges of patients particularly with
diet. With reference to South Asia, diet transition is significant
part of disease management, and it poses high barrier for
patient compliance. Most diabetics are accustomed to refined
carbohydrate with high glycemic index (GI) food. They have
difficulty following dietary recommendation for long term.
The likely causes of poor adherence are headaches, craving for
carbohydrates, habituation for their preferred food choices like
white rice, noodles and bread. We are developing a composite
to incorporate it into raw food ingredients. Aim is to enable food
production with lower GI. It will potentially help in addressing
the challenges of nutritional adherence in diabetic patients.
Although further research is needed to understand and explore
this route, nevertheless it offers a promising route to replace
high GI products with medium/low GI products.
Speaker Biography
Ahmad Hussen Tareq is pharmacist and scientist who did extensive work in peptide
engineering, its application in infectious diseases drug development and nutrition sciences.
After completing his PhD from NTU, Singapore, he has been extensively involved with
the deep tech startup ecosystem of Singapore. Recently he is building his own startup
focused on developing optimized nutritional care and behavior compliance for diabetics.
As a pharmacist, he worked with numerous diabetic patients, particularly in developing
countries with aim of reversing type 2 diabetes. His work is focused on using integrated
approach of behavior management, AI, sports science, big data, optimized nutritional &
pharmaceutical care.
e:
ahmadhus001@gmail.com